Dr. Amanda Rodriguez Betancourt | Surgical Site Infections | Best Researcher Award

Posted on by Pencis

Dr. Amanda Rodriguez Betancourt | Surgical Site Infections | Best Researcher Award

UNIVERSITY OF ILLINOIS AT CHICAGO | United States.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

Dr. Amanda Beatriz Rodriguez Betancourt began her academic journey with a Doctor of Dental Surgery (DDS) degree from Universidad Santa María in Venezuela. With a profound interest in periodontology and surgical precision, she later pursued a Master of Science in Periodontics from the prestigious Pontificia Universidad Javeriana, Colombia. Her early education laid the groundwork for a dynamic career that seamlessly merges clinical excellence, scientific rigor, and a deep commitment to patient-centered care.

💼PROFESSIONAL ENDEAVORS

Dr. Rodriguez Betancourt has held notable roles in both academic and clinical settings across Latin America and the United States. She served as Assistant Program Director and Research Fellow in the Graduate Periodontics Program at the University of Michigan, where she also co-directed the Periodontal, Implant, and Microsurgery Academy (PiMA). She is currently advancing her training through a Master’s in Oral Sciences and a Certificate in Periodontics at the University of Illinois Chicago (UIC).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON SURGICAL SITE INFECTIONS

A key area of Dr. Rodriguez Betancourt’s scholarly contributions is Surgical Site Infections (SSIs) within periodontology and implantology. Her research delves into early-stage detection, wound healing dynamics, and tissue perfusion assessments using Laser Speckle Contrast Imaging (LSCI) and 3D intraoral scanning. By integrating ultrasound imaging, CBCT-guided planning, and CAD/CAM technology, her studies aim to minimize post-operative complications, particularly SSIs, in both soft- and hard-tissue surgical sites. These efforts are helping redefine protocols for infection control, minimally invasive surgery, and clinical decision-making in complex periodontal cases.

🌍IMPACT AND INFLUENCE

Dr. Rodriguez Betancourt’s work has influenced both clinical and academic communities through her interdisciplinary collaborations, translational research, and dedication to evidence-based dentistry. Her expertise in imaging-driven diagnostics and microsurgical techniques has directly impacted peri-implant therapy, graft survival, and SSI prevention protocols. She is recognized for advancing a precision-medicine approach in periodontology, promoting personalized care grounded in digital data.

🏆RESEARCH GRANTS AND FUNDING

While serving at the University of Michigan, Dr. Rodriguez Betancourt contributed to NIH-funded studies exploring the pathophysiology of periodontitis and implant-associated infections. She has participated in multi-center clinical trials and currently engages in grant-supported research at UIC, focusing on oral tissue response to biomaterials and novel imaging for surgical monitoring.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Rodriguez Betancourt’s legacy is rooted in her commitment to translational research, cross-disciplinary education, and clinical innovation. Her future goals include leading global collaborations to develop standardized imaging protocols for early SSI detection and shaping next-generation training curricula in periodontal diagnostics and infection control. She envisions a future where digital health technologies empower dentists to detect infections before clinical symptoms emerge.

🌟A VISIONARY IN INFECTIOUS DISEASES

Through her visionary work, Dr. Amanda Rodriguez Betancourt stands at the intersection of periodontal surgery and infectious disease research. Her pursuit of innovation, clinical excellence, and academic mentorship underscores her role as a transformative leader in dental medicine. Her mission is clear: to elevate global standards in oral health, reduce post-surgical infection rates, and bring cutting-edge science into the hands of everyday clinicians.

📑NOTABLE PUBLICATIONS

🧪Introduction of “MAPS” Wound Healing Index and Its Correlation with Guided Bone Regeneration Outcome

Authors: Amanda Rodriguez, Tanay Chaubal, Diego Velasquez, Leonardo Marquez, Jose Maria Ramos, Nataly Zambrana, Maria Masotti, Oliver Kripfgans, Hsun-Liang Chan
Year: 2025
Journal: PLOS ONE

🧪Minimally Invasive Sinus Augmentation: A Systematic Review

Authors: Benyapha Sirinirund, Amanda B. Rodriguez Betancourt, Riccardo Scaini, Yu‐Chang Wu, Hsun‐Liang Chan
Year: 2025
Journal: Clinical Implant Dentistry and Related Research

🧪Ultrasound‐Based Jawbone Surface Quality Evaluation After Alveolar Ridge Preservation

Authors: Amanda B. Rodriguez, Oliver D. Kripfgans, Kenneth M. Kozloff, Ankita Samal, Jae‐man Woo, Mostafa Shehabeldin, Hsun‐Liang Chan
Year: 2024
Journal: Journal of Periodontology

🧪The Use of Digital Technologies in Peri‐Implant Soft Tissue Augmentation – A Narrative Review on Planning, Measurements, Monitoring and Aesthetics

Authors: Franz Josef Strauss, Alfonso Gil, Rawen Smirani, Amanda Rodriguez, Ronald Jung, Daniel Thoma
Year: 2024
Journal: Clinical Oral Implants Research

🧪Intraoral Ultrasonography Image Registration for Evaluation of Partial Edentulous Ridge: A Methodology and Validation Study

Authors: Amanda Rodriguez, Oliver Kripfgans, Priscila Ceolin Meneghetti, Gustavo Mendonça, Rafael Pereira, Wendel Teixeira, Nataly Zambrana, Ankita Samal, Hsun-Liang Chan
Year: 2024
Journal: Journal of Dentistry

Yi HSin Wang | Antibiotic | Best Researcher Award

Posted on by Pencis

Yi HSin Wang | Antibiotic | Best Researcher Award

Assist Prof Dr. Yi HSin Wang , Chung Shan Medical University, Taiwan.

Assist Prof Dr. Yi Hsin Wang is a dedicated researcher specializing in antibiotic discovery and development. With a strong academic foundation in microbiology and pharmacology, she has contributed significantly to the understanding of antibiotic resistance mechanisms and the identification of novel antimicrobial agents. Her work focuses on developing innovative strategies to combat bacterial infections, making a profound impact on public health. Yi Hsin has published numerous articles in peer-reviewed journals and has presented her research at international conferences, showcasing her commitment to advancing the field of antibiotic research. Her dedication to scientific excellence and her contributions to antibiotic development make her a deserving candidate for the Best Researcher Award.

Profile:

Scopus  Profile

Education

Assist Prof Dr. Yi-Hsin Wang pursued his academic journey at Chung Shan Medical University, beginning with a Bachelor of Science degree in Medical Applied Chemistry from 2008 to 2012. He then advanced to the Institute of Medicine at the same university, completing a Master of Science degree from 2012 to 2014 under the guidance of Professors Jinghua Tsai Chang and Shiang-Suo Huang. Building upon his research foundation, Yi-Hsin continued his studies in the Institute of Medicine, where he earned his Ph.D. from 2014 to 2018, with Professors Jinghua Tsai Chang and Shiang-Suo Huang as his advisors once again.

 

Experience 

Assist Prof Dr. Yi-Hsin Wang currently holds the position of Assistant Professor in the Department of Physiology at Chung Shan Medical University’s School of Medicine (2022.08–present). Previously, Wang served as a Postdoctoral Researcher in the Department of Pharmacology at China Shan Medical University’s School of Medicine (2019.08–2022.07) and in the Graduate Institute of Acupuncture Science at China Medical University (2018.09–2019.07), with a strong focus on physiology, pharmacology, and acupuncture science throughout their academic and research career.

 

Skills

Assist Prof Dr. Yi-Hsin Wang possesses a range of experimental skills, including expertise in creating animal models for myocardial infarction and ischemic stroke. Additionally, Wang is proficient in Western blotting, gelatin zymography, and immunohistochemistry, each essential for analyzing protein expression, enzyme activity, and tissue-specific antigen localization.

 

Awards

Assist Prof Dr. Yi-Hsin Wang has received notable awards for contributions to biomedical sciences, including the Young Scientist Travel Award at the 9th FAOPS Congress (2019) in Japan and 2nd place in the Poster Award at the 33rd Joint Annual Conference of Biomedical Sciences (2018) in Taiwan.

 

Research Skills

Assist Prof Dr. Yi-Hsin Wang research expertise encompasses a diverse range of fields, including cardiology, with a focus on cardioprotection, and extends to neuroscience, particularly in the area of neuroprotection. His work also addresses the mechanisms underlying ischemia/reperfusion injury, contributing to a deeper understanding of both brain and cardiovascular physiology.

Top Note Publications

Title: Dunaliella salina Alga Protects against Myocardial Ischemia/Reperfusion Injury by Attenuating TLR4 Signaling

Authors: Tsai, C.-F., Lin, H.-W., Liao, J.-M., … Wang, M., Huang, S.-S.
Year: 2023
Citations: 4

Title: Lumbrokinase Regulates Endoplasmic Reticulum Stress to Improve Neurological Deficits in Ischemic Stroke

Authors: Wang, Y.-H., Liao, J.-M., Chen, K.-M., … Tsai, C.-F., Huang, S.-S.
Year: 2022
Citations: 5

Title: Activation of Peripheral TRPM8 Mitigates Ischemic Stroke by Topically Applied Menthol

Authors: Huang, S.-S., Su, H.-H., Chien, S.-Y., … Lee, H.-H., Chen, Y.-H.
Year: 2022
Citations: 14

Title: In Situ Slow-Release Recombinant Growth Differentiation Factor 11 Exhibits Therapeutic Efficacy in Ischemic Stroke

Authors: Su, H.-H., Yen, J.-C., Liao, J.-M., … Chen, Y.-H., Huang, S.-S.
Year: 2021
Citations: 5

Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk

Authors: Tsai, C.-F., Su, H.-H., Chen, K., … Wang, Y.-H., Huang, S.-S.
Year: 2021
Citations: 27

Introduction of Antibiotic

Posted on by Pencis

Introduction of Antibiotic

Antibiotics are powerful medications used to treat infections caused by bacteria. They work by killing bacteria or inhibiting their growth, helping to cure infections that would otherwise become severe or life-threatening. Antibiotics have revolutionized modern medicine since their discovery, drastically reducing mortality from bacterial infections. However, the misuse and overuse of antibiotics have led to increasing levels of antibiotic resistance, posing a significant threat to global health.

  • Types of Antibiotics:
  1. Broad-spectrum Antibiotics:
    These antibiotics work against a wide variety of bacteria, both Gram-positive and Gram-negative. Examples include:

    • Amoxicillin
    • Tetracycline
    • Ciprofloxacin
  2. Narrow-spectrum Antibiotics:
    These antibiotics target specific types of bacteria. Examples include:

    • Penicillin G (used mainly against Gram-positive bacteria)
    • Vancomycin (used against resistant Gram-positive bacteria)
  3. Bactericidal Antibiotics:
    These kill bacteria by attacking their cell walls or vital cellular functions. Examples include:

    • Penicillin
    • Cephalosporins
    • Aminoglycosides
  4. Bacteriostatic Antibiotics:
    These inhibit bacterial growth by interfering with bacterial protein production or DNA replication. Examples include:

    • Tetracycline
    • Sulfonamides
    • Chloramphenicol
  • How Antibiotics Work:
  • Antibiotics target key processes in bacteria that are essential for their survival and replication. These include:
  • Cell wall synthesis inhibition: Prevents bacteria from forming cell walls, leading to cell death (e.g., Penicillin).
  • Protein synthesis inhibition: Disrupts bacterial ribosomes, which produce proteins essential for cell function (e.g., Tetracycline).
  • DNA replication inhibition: Prevents bacterial DNA replication, halting cell division (e.g., Quinolones).
  • Cell membrane disruption: Damages bacterial cell membranes, leading to cell death (e.g., Polymyxins).

    Examples of Antibiotic-Resistant Bacteria:

    1. Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to many antibiotics, causing serious skin infections.
    2. Vancomycin-resistant Enterococci (VRE): Often found in hospital-acquired infections.
    3. Carbapenem-resistant Enterobacteriaceae (CRE): Highly resistant to most antibiotics and often fatal.
    4. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB): Resistant to the two most powerful anti-TB drugs, requiring complex and prolonged treatment.
  • Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

Introduction of Animal Infectious Diseases
Introduction of Animal infectious diseases Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species.